| Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors S Bukhari, BS Henick, RJ Winchester, S Lerrer, K Adam, Y Gartshteyn, ... Cell Reports Medicine 4 (1), 2023 | 35 | 2023 |
| Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy R Maniar, PH Wang, RS Washburn, R Kratchmarov, SM Coley, A Saqi, ... Cancer immunology research 11 (2), 164-170, 2023 | 13 | 2023 |
| Understanding the landscape of immunotherapy in thymic epithelial tumors R Maniar, PJ Loehrer Sr Cancer 129 (8), 1162-1172, 2023 | 9 | 2023 |
| Extracutaneous melanoma R Carvajal, R Maniar Hematology/Oncology Clinics 35 (1), 85-98, 2021 | 7 | 2021 |
| Metabolic interplay in the tumor microenvironment: implications for immune function and anticancer response R Youssef, R Maniar, J Khan, H Mesa Current Issues in Molecular Biology 45 (12), 9753-9767, 2023 | 6 | 2023 |
| Cutting edge: Promoting T cell factor 1+ T cell self-renewal to improve programmed cell death protein 1 blockade PH Wang, R Washburn, R Maniar, M Mu, O Ringham, R Kratchmarov, ... The Journal of Immunology 209 (4), 660-664, 2022 | 5 | 2022 |
| Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report F Ardeshir-Larijani, R Maniar, S Goyal, PJ Loehrer, T Hou, V DeBrock, ... Clinical Lung Cancer 25 (2), 180-185. e1, 2024 | 3 | 2024 |
| What Have We Learned from Molecularly Informed Clinical Trials on Thymomas and Thymic Carcinomas—Current Status and Future Directions? R Maniar, PJ Loehrer Sr Cancers 16 (2), 416, 2024 | 2 | 2024 |
| Baseline demographics and disparities in cancer registration trials: An analysis of US Food and Drug Administration approved drugs in 2015 and 2016. R Maniar, A Green, P Bach, S Mailankody Journal of Clinical Oncology 36 (15_suppl), e18623-e18623, 2018 | 2 | 2018 |
| Unusual Adverse Events in a Patient With BRAF-Mutated Non–Small Cell Lung Cancer Treated With BRAF/MEK Inhibition R Maniar, SM Gallitano, S Husain, G Moazami, MJ Weiss, CA Shu Journal of the National Comprehensive Cancer Network 21 (3), 232-234, 2023 | 1 | 2023 |
| Case of Merkel cell carcinoma in a patient with pre-existing ILD R Maniar, M Anderson, B Taback, S Khan, D McDonnell, A Saqi, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 1 | 2020 |
| Defining the needle in a Haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors MD Shields, KG Minton, M Tran, PR Gunderman, LG Larsson, S Guo, ... Lung Cancer, 108035, 2024 | | 2024 |
| MA15. 07 Preliminary Analysis of Adjuvant Chemotherapy with Atezolizumab in Stage I-III Resected NSCLC and Clearance of ctDNA R Maniar, E Shum, NA Mohindra, DH Owen, PC Ma, M Haigentz, RD Hall, ... Journal of Thoracic Oncology 19 (10), S117-S118, 2024 | | 2024 |
| P2. 14A. 12 Unveiling COL17A1 as a Novel Cell Surface Target in Thymic Epithelial Tumors: A Target Discovery Pipeline Approach FA Larijani, F Perna, H Mesa, VA DeBrock, TA Augustine, LA Baldrige, ... Journal of Thoracic Oncology 19 (10), S277-S278, 2024 | | 2024 |
| Comprehensive molecular characterization of thymic epithelial tumors. C Kim, TT Adeyelu, R Maniar, AP Farrell, JP Zaemes, JP Solzak, ... Journal of Clinical Oncology 42 (16_suppl), 8113-8113, 2024 | | 2024 |
| Metabolic augmentation to promote and enhance immune response by tcf1+ t cell repopulation SL Reiner, BS Henick, NA Rizvi, R Maniar US Patent App. 18/245,797, 2024 | | 2024 |
| Management of stage IVA (M1a) thymoma: observation versus chemotherapy versus surgery versus radiation therapy? KA Kesler, R Maniar, PJ Loehrer Mediastinum 8, 2024 | | 2024 |
| AB018. Local recurrence of thymoma following minimally invasive resection: a retrospective case series HO Davis, EM Heldman, LJ Laniak, BS Wuthrich, SS Badve, HA Mesa, ... Mediastinum 7, 2023 | | 2023 |
| AB025. Evaluation of potential therapeutic immunohistochemical targets with experimental or FDA-approved therapies in thymic epithelial tumor microarrays F Ardeshir-Larijani, PJ Loehrer, R Maniar, T Hou, V DeBrock, H Mesa Mediastinum 7, 2023 | | 2023 |
| Developing Cell Surface Target Discovery Pipeline in Metastatic Thymic Epithelial Tumors (mTET) F Perna, H Messa, TA Augustine, LA Baldrige, V DeBrock, E Liu, T Hou, ... International Journal of Cancer Care and Delivery 3 (Supplement 2), 2023 | | 2023 |
